Literature DB >> 18281669

Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.

Donald W Hadley1, Jean F Jenkins, Seth M Steinberg, David Liewehr, Stephanie Moller, Jean C Martin, Kathleen A Calzone, Peter W Soballe, Ilan R Kirsch.   

Abstract

PURPOSE: Lynch syndrome poses multiple cancer risks, yet attention has focused on screening for colorectal cancer. Estimated risks for endometrial cancer equal risks for colorectal cancer. This study (1) evaluated women's perceived risks for cancers, (2) compared endometrial cancer screening and colonoscopy, and (3) identified predictors of screening before and after genetic testing. PATIENTS AND METHODS: Sixty-five adult women at 50% risk for carrying a cancer-predisposing mutation, without a history of endometrial cancer or hysterectomy, participated in genetic counseling and received unequivocal genetic test results for Lynch syndrome. Participants completed questionnaires before and after receipt of genetic results.
RESULTS: Pretest, perceived risks for colon cancer were significantly higher than for extracolonic cancers (P < .0001). Use of colonoscopy was significantly higher (P = .006) than endometrial cancer screening. Post-test, carriers demonstrated a significant (P < .0001) increase in their perceived risk for extracolonic cancers and increased both colonoscopy (P = .79) and endometrial cancer screening (P = .11). Mutation status, age, perceived likelihood of carrying a mutation, and communication of test results to their physician independently predicted cancer screening at follow-up.
CONCLUSION: Women in families with Lynch syndrome are less aware of their risks for extracolonic cancers and undergo endometrial cancer screening significantly less often than colonoscopy before genetic counseling. Given the significantly increased risks for endometrial and ovarian cancers and the mortality associated with ovarian cancer, additional efforts to inform families of cancer risks and screening recommendations seem prudent. Physicians play a critical role in ensuring appropriate cancer screening in women with Lynch syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18281669     DOI: 10.1200/JCO.2007.13.0575

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  22 in total

Review 1.  Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice.

Authors:  Kimberly A Kaphingst; Colleen M McBride
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

2.  Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency.

Authors:  Lior H Katz; Shailesh Advani; Allison M Burton-Chase; Bryan Fellman; Katrina M Polivka; Ying Yuan; Patrick M Lynch; Susan K Peterson
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

3.  Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation.

Authors:  D W Hadley; S Ashida; J F Jenkins; K A Calzone; I R Kirsch; L M Koehly
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

4.  Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Authors:  Uri Ladabaum; Grace Wang; Jonathan Terdiman; Amie Blanco; Miriam Kuppermann; C Richard Boland; James Ford; Elena Elkin; Kathryn A Phillips
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

5.  Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.

Authors:  A M Burton-Chase; S R Hovick; S K Peterson; S K Marani; S W Vernon; C I Amos; M L Frazier; P M Lynch; E R Gritz
Journal:  Clin Genet       Date:  2013-03       Impact factor: 4.438

6.  The Impact of Receiving Predictive Genetic Information about Lynch Syndrome on Individual Colonoscopy and Smoking Behaviors.

Authors:  Joanne Soo-Min Kim; Peter C Coyte; Michelle Cotterchio; Louise A Keogh; Louisa B Flander; Clara Gaff; Audrey Laporte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-15       Impact factor: 4.254

7.  Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome.

Authors:  Shilpa Grover; Elena M Stoffel; Rowena C Mercado; Beth M Ford; Wendy K Kohlman; Kristen M Shannon; Peggy G Conrad; Amie M Blanco; Jonathan P Terdiman; Stephen B Gruber; Daniel C Chung; Sapna Syngal
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

Review 8.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

9.  Colon cancer screening practices and disclosure after receipt of positive or inconclusive genetic test results for hereditary nonpolyposis colorectal cancer.

Authors:  Anne L Ersig; Donald W Hadley; Laura M Koehly
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

Review 10.  Therapeutic options for the management of pancreatic cancer.

Authors:  Maria L Rossi; Azeem A Rehman; Christopher S Gondi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.